Prolonged impacts of COVID-19-associated cystitis: A study on long-term consequences.

Document Type

Article

Publication Date

11-26-2023

Publication Title

World journal of clinical cases

Abstract

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 virus is an international health concern with substantial morbidity and mortality. COVID-associated cystitis (CAC), presents as new onset or exacerbated urinary symptoms, resembling overactive bladder (OAB) symptoms.

AIM: To examines the long-term outcomes of patients with CAC in the context of Long COVID.

METHODS: A cohort of 350 patients admitted to Detroit Hospitals with COVID-19 between May and December 2020, displaying CAC symptoms following discharge, was prospectively followed. Initial urologic evaluations occurred at 10-14 wk and were repeated at 21-28 mo post-discharge. Symptoms were managed conservatively, employing behavioral modifications and standard OAB medications. Participants completed surveys assessing urinary symptoms and quality of life (QoL) at both time points. The primary outcome was the Urology Care Foundation Overactive Bladder Assessment Tool.

RESULTS: 87% of the final cohort (

CONCLUSION: This study presents the first long-term follow-up of adult patients with CAC, revealing a promising prognosis with conservative management measures in the context of Long COVID. These findings provide reassurance to patients regarding symptom resolution and underscore the need for further research into this evolving aspect of COVID-19's impact on urological health.

Volume

11

Issue

33

First Page

7987

Last Page

7993

DOI

10.12998/wjcc.v11.i33.7987

ISSN

2307-8960

PubMed ID

38075566

Link to Full Text

Share

COinS